Kirtane, Ameya R.

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 520

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy

Kirtane, A. R., Abouzid, O., Minahan, D., Bensel, T., Hill, A. L., Selinger, C., Bershteyn, A., Craig, M., Mo, S. S., Mazdiyasni, H., et al. (2018) · Nature Communications

Advanced Drug Delivery SystemsHIV/AIDS drug development and treatment

Cited by 227

Gastrointestinal synthetic epithelial linings

Li, J., Wang, T., Kirtane, A. R., Shi, Y., Jones, A., Moussa, Z., Lopes, A., Collins, J., Tamang, S. M., Hess, K., et al. (2020) · Science Translational Medicine

Polymer Surface Interaction StudiesTissue Engineering and Regenerative Medicine

Cited by 70

Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine

Kirtane, A. R., Sadhukha, T., Kim, H., Khanna, V., Koniar, B., & Panyam, J. (2017) · Cancer Research

Nanoparticle-Based Drug DeliveryUltrasound and Hyperthermia Applications

Cited by 38

Past, Present, and Future Drug Delivery Systems for Antiretrovirals

Kirtane, A. R., Langer, R., & Traverso, G. (2016) · Journal of Pharmaceutical Sciences

HIV/AIDS drug development and treatmentAdvanced Drug Delivery Systems

Cited by 28

Assessing the benefits of drug delivery by nanocarriers: a partico/pharmacokinetic framework

Siegel, R. A., Kirtane, A. R., & Panyam, J. (2017) · IEEE Transactions on Biomedical Engineering

Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

Cited by 14